See more : Sumitomo Chemical Company, Limited (SOMMY) Income Statement Analysis – Financial Results
Complete financial analysis of Ikonisys S.A. (ALIKO.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ikonisys S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- G2 Goldfields Inc. (GTWO.TO) Income Statement Analysis – Financial Results
- Global Industrial Company (GIC) Income Statement Analysis – Financial Results
- General Moly, Inc. (GMO.TO) Income Statement Analysis – Financial Results
- TKB Critical Technologies 1 (USCTU) Income Statement Analysis – Financial Results
- PT Wahana Pronatural Tbk (WAPO.JK) Income Statement Analysis – Financial Results
Ikonisys S.A. (ALIKO.PA)
About Ikonisys S.A.
Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe. It offers Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, and real-time image capture and analysis, and eliminates various factors that cause human error in testing; oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; and oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of rearrangements of the gene encoding anaplastic lymphoma kinase (ALK). The company also provides oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer CS, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; Ikonisoft explorer tissue, a FISH scanning application for analysis of various tissue section hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. Ikonisys S.A. is based in Paris, France.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 448.56K | 935.22K | 99.10K | 99.83K | 68.43K |
Cost of Revenue | 192.73K | 183.41K | 70.64K | 27.05K | 63.68K |
Gross Profit | 255.83K | 751.81K | 28.46K | 72.77K | 4.75K |
Gross Profit Ratio | 57.03% | 80.39% | 28.72% | 72.90% | 6.94% |
Research & Development | 1.38M | 45.17K | 37.91K | 0.00 | 0.00 |
General & Administrative | 770.54K | 645.69K | 415.83K | 9.52K | 15.57K |
Selling & Marketing | 349.48K | 234.81K | 43.59K | 0.00 | 0.00 |
SG&A | 1.12M | 880.50K | 415.83K | 9.52K | 15.57K |
Other Expenses | -52.97K | 2.26M | 352.13K | 243.89K | 240.03K |
Operating Expenses | 2.45M | 3.19M | 805.88K | 253.41K | 255.60K |
Cost & Expenses | 2.64M | 3.37M | 876.52K | 280.46K | 319.28K |
Interest Income | 0.00 | 13.54K | 5.11K | 1.77M | 0.00 |
Interest Expense | 73.92K | 13.54K | 5.11K | 1.77M | 1.62M |
Depreciation & Amortization | 42.82K | 1.08M | 80.58K | 68.18K | 70.80K |
EBITDA | -2.35M | -1.35M | -483.65K | 0.00 | -180.05K |
EBITDA Ratio | -523.35% | -144.53% | -703.19% | -112.66% | -263.12% |
Operating Income | -2.19M | -2.43M | -777.42K | -180.64K | -250.85K |
Operating Income Ratio | -489.06% | -260.34% | -784.50% | -180.95% | -366.59% |
Total Other Income/Expenses | -73.92K | -13.54K | -5.11K | -1.77M | -1.62M |
Income Before Tax | -2.27M | -2.45M | -934.48K | -1.95M | -1.87M |
Income Before Tax Ratio | -505.54% | -261.79% | -942.99% | -1,954.71% | -2,738.23% |
Income Tax Expense | 0.00 | 57.74K | 1.93K | 6.30K | 5.05K |
Net Income | -2.27M | -2.51M | -936.41K | -1.96M | -1.88M |
Net Income Ratio | -505.54% | -267.96% | -944.94% | -1,961.02% | -2,745.62% |
EPS | -0.22 | -0.26 | -0.10 | -0.20 | -0.19 |
EPS Diluted | -0.22 | -0.26 | -0.10 | -0.20 | -0.19 |
Weighted Avg Shares Out | 10.45M | 9.48M | 9.48M | 9.71M | 9.71M |
Weighted Avg Shares Out (Dil) | 10.45M | 9.48M | 9.48M | 9.71M | 9.71M |
Source: https://incomestatements.info
Category: Stock Reports